Both in Biotechnology
Immunovant vs Scholar Rock Holding
Over the past year IMVT returned +23.8% and SRRK returned +60.5%; their daily moves had a correlation of 0.34.
IMVT +23.8% SRRK +60.5%Growth of $1, one year, split-adjusted
| Metric | IMVT | SRRK |
|---|---|---|
| Price | $29.44 | $46.18 |
| Market cap | $6.08B | $5.62B |
| Today | +1.36% | +5.00% |
| 1 month | −8.3% | +8.8% |
| 6 months | +2.7% | −2.0% |
| Year to date | +15.8% | +4.8% |
| 1 year | +23.8% | +60.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $797.8M | $295.9M |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 44.9% |
| Short % of float | 21.1% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).